Dyskeratosis congenita and the DNA damage response
Summary Dyskeratosis congenita (DC) is a heterogeneous bone marrow failure disorder with known mutations in components of telomerase and telomere shelterin. Recent work in a mouse model with a dyskerin mutation has implicated an increased DNA damage response as part of the cellular pathology, while...
Gespeichert in:
Veröffentlicht in: | British journal of haematology 2011-06, Vol.153 (5), p.634-643 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 643 |
---|---|
container_issue | 5 |
container_start_page | 634 |
container_title | British journal of haematology |
container_volume | 153 |
creator | Kirwan, Michael Beswick, Richard Walne, Amanda J. Hossain, Upal Casimir, Colin Vulliamy, Tom Dokal, Inderjeet |
description | Summary
Dyskeratosis congenita (DC) is a heterogeneous bone marrow failure disorder with known mutations in components of telomerase and telomere shelterin. Recent work in a mouse model with a dyskerin mutation has implicated an increased DNA damage response as part of the cellular pathology, while mouse models with Terc and Tert mutations displayed a normal response. To clarify how these contradictory results might apply to DC pathology in humans, we studied the cellular phenotype in primary cells from DC patients of several genetic subtypes, focussing on T lymphocytes to remain close to the haematopoietic system. We observed novel cell cycle abnormalities in conjunction with impaired growth and an increase in apoptosis. Using flow cytometry and confocal microscopy we examined induction of the DNA damage proteins γ‐H2AX and 53BP1 and the cell cycle protein TP53 (p53). We found an increase in damage foci at telomeres in lymphocytes and an increase in the basal level of DNA damage in fibroblasts, but crucially no increased response to DNA damaging agents in either cell type. As the response to induced DNA damage was normal and levels of global DNA damage were inconsistent between cell types, DNA damage may contribute differently to the pathology in different tissues. |
doi_str_mv | 10.1111/j.1365-2141.2011.08679.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3328754</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>904474881</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5699-f2cd2e40b6124aa3b1dad4ab64a83743215eca040c4b59c394800838a0f72ed03</originalsourceid><addsrcrecordid>eNqNkU2P0zAQhi0EYsvCX0C5IMQhYfwRxz6AVHaBgiq4wNmaOJM2JU2KnS7bf09CS_m4gC-2_D7zesYvYwmHjI_r-SbjUuep4IpnAjjPwOjCZrd32Ows3GUzAChSDspcsAcxbgC4hJzfZxejXhQC7IyJ60P8QgGHPjYx8X23oq4ZMMGuSoY1Jdcf5kmFW1xREiju-i7SQ3avxjbSo9N-yT6_ef3papEuP759dzVfpj7X1qa18JUgBaXmQiHKkldYKSy1QiMLJQXPySMo8KrMrZdWGQAjDUJdCKpAXrKXR9_dvtxS5akbArZuF5othoPrsXF_Kl2zdqv-xkkpTJGr0eDZ0WD9V9livnTTHYCWIAy_4SP79PRY6L_uKQ5u20RPbYsd9fvoLChVKGP-TRqtQY3D2ZE0R9KHPsZA9bkJDm7K0W3cFJeb4nJTju5Hju52LH38--znwp_BjcCTE4DRY1sH7HwTf3GKGyv19Acvjty3pqXDfzfgXr1fTCf5Ha9yttU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>866042159</pqid></control><display><type>article</type><title>Dyskeratosis congenita and the DNA damage response</title><source>Wiley Free Content</source><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Kirwan, Michael ; Beswick, Richard ; Walne, Amanda J. ; Hossain, Upal ; Casimir, Colin ; Vulliamy, Tom ; Dokal, Inderjeet</creator><creatorcontrib>Kirwan, Michael ; Beswick, Richard ; Walne, Amanda J. ; Hossain, Upal ; Casimir, Colin ; Vulliamy, Tom ; Dokal, Inderjeet</creatorcontrib><description>Summary
Dyskeratosis congenita (DC) is a heterogeneous bone marrow failure disorder with known mutations in components of telomerase and telomere shelterin. Recent work in a mouse model with a dyskerin mutation has implicated an increased DNA damage response as part of the cellular pathology, while mouse models with Terc and Tert mutations displayed a normal response. To clarify how these contradictory results might apply to DC pathology in humans, we studied the cellular phenotype in primary cells from DC patients of several genetic subtypes, focussing on T lymphocytes to remain close to the haematopoietic system. We observed novel cell cycle abnormalities in conjunction with impaired growth and an increase in apoptosis. Using flow cytometry and confocal microscopy we examined induction of the DNA damage proteins γ‐H2AX and 53BP1 and the cell cycle protein TP53 (p53). We found an increase in damage foci at telomeres in lymphocytes and an increase in the basal level of DNA damage in fibroblasts, but crucially no increased response to DNA damaging agents in either cell type. As the response to induced DNA damage was normal and levels of global DNA damage were inconsistent between cell types, DNA damage may contribute differently to the pathology in different tissues.</description><identifier>ISSN: 0007-1048</identifier><identifier>EISSN: 1365-2141</identifier><identifier>DOI: 10.1111/j.1365-2141.2011.08679.x</identifier><identifier>PMID: 21477209</identifier><identifier>CODEN: BJHEAL</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adolescent ; Adult ; Apoptosis - genetics ; Biological and medical sciences ; cell cycle ; Cell Cycle - genetics ; Child, Preschool ; Dermatology ; DNA Damage ; dyskeratosis congenita ; Dyskeratosis Congenita - genetics ; Dyskeratosis Congenita - immunology ; Dyskeratosis Congenita - metabolism ; Female ; Fibroblasts - metabolism ; Hematologic and hematopoietic diseases ; Histones - metabolism ; Humans ; Intracellular Signaling Peptides and Proteins - metabolism ; lymphocytes ; Male ; Medical sciences ; Microscopy, Confocal ; Paediatric ; Pigmentary diseases of the skin ; T-Lymphocytes - metabolism ; T-Lymphocytes - pathology ; Telomere - genetics ; telomeres ; Tissue Culture Techniques ; Tumor Suppressor p53-Binding Protein 1 ; Tumor Suppressor Protein p53 - metabolism ; Up-Regulation - genetics ; Young Adult</subject><ispartof>British journal of haematology, 2011-06, Vol.153 (5), p.634-643</ispartof><rights>2011 Blackwell Publishing Ltd</rights><rights>2015 INIST-CNRS</rights><rights>2011 Blackwell Publishing Ltd.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><rights>2011 Blackwell Publishing Ltd 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5699-f2cd2e40b6124aa3b1dad4ab64a83743215eca040c4b59c394800838a0f72ed03</citedby><cites>FETCH-LOGICAL-c5699-f2cd2e40b6124aa3b1dad4ab64a83743215eca040c4b59c394800838a0f72ed03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2141.2011.08679.x$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2141.2011.08679.x$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,1411,1427,27901,27902,45550,45551,46384,46808</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24189364$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21477209$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-00630281$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Kirwan, Michael</creatorcontrib><creatorcontrib>Beswick, Richard</creatorcontrib><creatorcontrib>Walne, Amanda J.</creatorcontrib><creatorcontrib>Hossain, Upal</creatorcontrib><creatorcontrib>Casimir, Colin</creatorcontrib><creatorcontrib>Vulliamy, Tom</creatorcontrib><creatorcontrib>Dokal, Inderjeet</creatorcontrib><title>Dyskeratosis congenita and the DNA damage response</title><title>British journal of haematology</title><addtitle>Br J Haematol</addtitle><description>Summary
Dyskeratosis congenita (DC) is a heterogeneous bone marrow failure disorder with known mutations in components of telomerase and telomere shelterin. Recent work in a mouse model with a dyskerin mutation has implicated an increased DNA damage response as part of the cellular pathology, while mouse models with Terc and Tert mutations displayed a normal response. To clarify how these contradictory results might apply to DC pathology in humans, we studied the cellular phenotype in primary cells from DC patients of several genetic subtypes, focussing on T lymphocytes to remain close to the haematopoietic system. We observed novel cell cycle abnormalities in conjunction with impaired growth and an increase in apoptosis. Using flow cytometry and confocal microscopy we examined induction of the DNA damage proteins γ‐H2AX and 53BP1 and the cell cycle protein TP53 (p53). We found an increase in damage foci at telomeres in lymphocytes and an increase in the basal level of DNA damage in fibroblasts, but crucially no increased response to DNA damaging agents in either cell type. As the response to induced DNA damage was normal and levels of global DNA damage were inconsistent between cell types, DNA damage may contribute differently to the pathology in different tissues.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Apoptosis - genetics</subject><subject>Biological and medical sciences</subject><subject>cell cycle</subject><subject>Cell Cycle - genetics</subject><subject>Child, Preschool</subject><subject>Dermatology</subject><subject>DNA Damage</subject><subject>dyskeratosis congenita</subject><subject>Dyskeratosis Congenita - genetics</subject><subject>Dyskeratosis Congenita - immunology</subject><subject>Dyskeratosis Congenita - metabolism</subject><subject>Female</subject><subject>Fibroblasts - metabolism</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Histones - metabolism</subject><subject>Humans</subject><subject>Intracellular Signaling Peptides and Proteins - metabolism</subject><subject>lymphocytes</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Microscopy, Confocal</subject><subject>Paediatric</subject><subject>Pigmentary diseases of the skin</subject><subject>T-Lymphocytes - metabolism</subject><subject>T-Lymphocytes - pathology</subject><subject>Telomere - genetics</subject><subject>telomeres</subject><subject>Tissue Culture Techniques</subject><subject>Tumor Suppressor p53-Binding Protein 1</subject><subject>Tumor Suppressor Protein p53 - metabolism</subject><subject>Up-Regulation - genetics</subject><subject>Young Adult</subject><issn>0007-1048</issn><issn>1365-2141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>EIF</sourceid><recordid>eNqNkU2P0zAQhi0EYsvCX0C5IMQhYfwRxz6AVHaBgiq4wNmaOJM2JU2KnS7bf09CS_m4gC-2_D7zesYvYwmHjI_r-SbjUuep4IpnAjjPwOjCZrd32Ows3GUzAChSDspcsAcxbgC4hJzfZxejXhQC7IyJ60P8QgGHPjYx8X23oq4ZMMGuSoY1Jdcf5kmFW1xREiju-i7SQ3avxjbSo9N-yT6_ef3papEuP759dzVfpj7X1qa18JUgBaXmQiHKkldYKSy1QiMLJQXPySMo8KrMrZdWGQAjDUJdCKpAXrKXR9_dvtxS5akbArZuF5othoPrsXF_Kl2zdqv-xkkpTJGr0eDZ0WD9V9livnTTHYCWIAy_4SP79PRY6L_uKQ5u20RPbYsd9fvoLChVKGP-TRqtQY3D2ZE0R9KHPsZA9bkJDm7K0W3cFJeb4nJTju5Hju52LH38--znwp_BjcCTE4DRY1sH7HwTf3GKGyv19Acvjty3pqXDfzfgXr1fTCf5Ha9yttU</recordid><startdate>201106</startdate><enddate>201106</enddate><creator>Kirwan, Michael</creator><creator>Beswick, Richard</creator><creator>Walne, Amanda J.</creator><creator>Hossain, Upal</creator><creator>Casimir, Colin</creator><creator>Vulliamy, Tom</creator><creator>Dokal, Inderjeet</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><general>Wiley</general><scope>24P</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>7TM</scope><scope>H94</scope><scope>1XC</scope><scope>VOOES</scope><scope>5PM</scope></search><sort><creationdate>201106</creationdate><title>Dyskeratosis congenita and the DNA damage response</title><author>Kirwan, Michael ; Beswick, Richard ; Walne, Amanda J. ; Hossain, Upal ; Casimir, Colin ; Vulliamy, Tom ; Dokal, Inderjeet</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5699-f2cd2e40b6124aa3b1dad4ab64a83743215eca040c4b59c394800838a0f72ed03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Apoptosis - genetics</topic><topic>Biological and medical sciences</topic><topic>cell cycle</topic><topic>Cell Cycle - genetics</topic><topic>Child, Preschool</topic><topic>Dermatology</topic><topic>DNA Damage</topic><topic>dyskeratosis congenita</topic><topic>Dyskeratosis Congenita - genetics</topic><topic>Dyskeratosis Congenita - immunology</topic><topic>Dyskeratosis Congenita - metabolism</topic><topic>Female</topic><topic>Fibroblasts - metabolism</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Histones - metabolism</topic><topic>Humans</topic><topic>Intracellular Signaling Peptides and Proteins - metabolism</topic><topic>lymphocytes</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Microscopy, Confocal</topic><topic>Paediatric</topic><topic>Pigmentary diseases of the skin</topic><topic>T-Lymphocytes - metabolism</topic><topic>T-Lymphocytes - pathology</topic><topic>Telomere - genetics</topic><topic>telomeres</topic><topic>Tissue Culture Techniques</topic><topic>Tumor Suppressor p53-Binding Protein 1</topic><topic>Tumor Suppressor Protein p53 - metabolism</topic><topic>Up-Regulation - genetics</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kirwan, Michael</creatorcontrib><creatorcontrib>Beswick, Richard</creatorcontrib><creatorcontrib>Walne, Amanda J.</creatorcontrib><creatorcontrib>Hossain, Upal</creatorcontrib><creatorcontrib>Casimir, Colin</creatorcontrib><creatorcontrib>Vulliamy, Tom</creatorcontrib><creatorcontrib>Dokal, Inderjeet</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kirwan, Michael</au><au>Beswick, Richard</au><au>Walne, Amanda J.</au><au>Hossain, Upal</au><au>Casimir, Colin</au><au>Vulliamy, Tom</au><au>Dokal, Inderjeet</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dyskeratosis congenita and the DNA damage response</atitle><jtitle>British journal of haematology</jtitle><addtitle>Br J Haematol</addtitle><date>2011-06</date><risdate>2011</risdate><volume>153</volume><issue>5</issue><spage>634</spage><epage>643</epage><pages>634-643</pages><issn>0007-1048</issn><eissn>1365-2141</eissn><coden>BJHEAL</coden><abstract>Summary
Dyskeratosis congenita (DC) is a heterogeneous bone marrow failure disorder with known mutations in components of telomerase and telomere shelterin. Recent work in a mouse model with a dyskerin mutation has implicated an increased DNA damage response as part of the cellular pathology, while mouse models with Terc and Tert mutations displayed a normal response. To clarify how these contradictory results might apply to DC pathology in humans, we studied the cellular phenotype in primary cells from DC patients of several genetic subtypes, focussing on T lymphocytes to remain close to the haematopoietic system. We observed novel cell cycle abnormalities in conjunction with impaired growth and an increase in apoptosis. Using flow cytometry and confocal microscopy we examined induction of the DNA damage proteins γ‐H2AX and 53BP1 and the cell cycle protein TP53 (p53). We found an increase in damage foci at telomeres in lymphocytes and an increase in the basal level of DNA damage in fibroblasts, but crucially no increased response to DNA damaging agents in either cell type. As the response to induced DNA damage was normal and levels of global DNA damage were inconsistent between cell types, DNA damage may contribute differently to the pathology in different tissues.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>21477209</pmid><doi>10.1111/j.1365-2141.2011.08679.x</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-1048 |
ispartof | British journal of haematology, 2011-06, Vol.153 (5), p.634-643 |
issn | 0007-1048 1365-2141 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3328754 |
source | Wiley Free Content; MEDLINE; Wiley Online Library Journals Frontfile Complete; EZB-FREE-00999 freely available EZB journals |
subjects | Adolescent Adult Apoptosis - genetics Biological and medical sciences cell cycle Cell Cycle - genetics Child, Preschool Dermatology DNA Damage dyskeratosis congenita Dyskeratosis Congenita - genetics Dyskeratosis Congenita - immunology Dyskeratosis Congenita - metabolism Female Fibroblasts - metabolism Hematologic and hematopoietic diseases Histones - metabolism Humans Intracellular Signaling Peptides and Proteins - metabolism lymphocytes Male Medical sciences Microscopy, Confocal Paediatric Pigmentary diseases of the skin T-Lymphocytes - metabolism T-Lymphocytes - pathology Telomere - genetics telomeres Tissue Culture Techniques Tumor Suppressor p53-Binding Protein 1 Tumor Suppressor Protein p53 - metabolism Up-Regulation - genetics Young Adult |
title | Dyskeratosis congenita and the DNA damage response |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T17%3A34%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dyskeratosis%20congenita%20and%20the%20DNA%20damage%20response&rft.jtitle=British%20journal%20of%20haematology&rft.au=Kirwan,%20Michael&rft.date=2011-06&rft.volume=153&rft.issue=5&rft.spage=634&rft.epage=643&rft.pages=634-643&rft.issn=0007-1048&rft.eissn=1365-2141&rft.coden=BJHEAL&rft_id=info:doi/10.1111/j.1365-2141.2011.08679.x&rft_dat=%3Cproquest_pubme%3E904474881%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=866042159&rft_id=info:pmid/21477209&rfr_iscdi=true |